Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response

Conditions: Melanoma Interventions: Drug: Nivolumab Sponsors: Erasmus Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials